文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

体外心肺复苏患者脉搏血氧饱和度与动脉血氧饱和度差异及死亡率:体外生命支持组织注册数据分析

Pulse Oximetry and Arterial Blood Gas Oxygen Saturation Discrepancies and Mortality in Extracorporeal Cardiopulmonary Resuscitation Patients: An Extracorporeal Life Support Organization Registry Analysis.
PubMed 文献 · Crit Care Med · 2025-06-16
一句话结论ECPR后24小时内SpO2-SaO2≥4%与院内死亡风险升高独立相关(aOR 1.39),可能源于未被识别的低氧血症。

该回顾性分析基于体外生命支持组织注册数据(496个ECMO中心,2018-2024年),纳入3970例接受ECPR的成人患者(中位年龄57岁,71%男性)。在ECMO支持24小时测量SpO2-SaO2差值,以 cubic spline 分析拐点确定的≥4%为二分类阈值。SpO2-SaO2≥4%组634例(16%),其院内死亡率67%(425例)高于<4%组的59%(1966例)(p<0.001);多因素校正后SpO2-SaO2≥4%与死亡风险升高相关(aOR 1.39;95%CI 1.13-1.71)。脑损伤、高氧血症(≥300 mmHg及200-299 mmHg)、消化道出血、肾脏替代治疗、低氧血症(<60 mmHg)、年龄及乳酸升高亦与死亡率升高相关。

要点

  • ECPR后24小时内SpO2-SaO2≥4%者院内死亡率67%(425例),显著高于<4%者的59%(1966例)(p<0.001)。
  • 多因素校正后SpO2-SaO2≥4%与死亡风险升高独立相关(aOR 1.39;95%CI 1.13-1.71)。
  • SpO2-SaO2≥4%组血清乳酸高于<4%组(3.1 vs. 2.8 mmol/L;p=0.0017)。
  • 急性脑损伤与死亡风险升高相关(aOR 5.81;95%CI 4.70-7.20),高氧血症≥300 mmHg亦相关(aOR 1.93;95%CI 1.53-2.43)。
  • 种族/民族与死亡率升高无关。

适用人群与场景

  • 年龄≥18岁、接受体外心肺复苏(ECPR)且为首次运行的患者,数据来自体外生命支持组织注册中心496个ECMO中心(2018-2024年)。

诊断标准与关键阈值

  • 在ECMO支持24小时测量SpO2-SaO2差值,基于 cubic spline 分析拐点,以SpO2-SaO2≥4%作为二分类阈值。
  • 急性脑损伤包括缺氧缺血性脑损伤、缺血性卒中、颅内出血和癫痫发作。

红旗征与不能漏的情况

  • SpO2-SaO2≥4%提示可能存在未被识别的低氧血症,与院内死亡风险升高相关(aOR 1.39;95%CI 1.13-1.71)。
  • 急性脑损伤与死亡风险升高相关(aOR 5.81;95%CI 4.70-7.20)。
  • 高氧血症≥300 mmHg与死亡风险升高相关(aOR 1.93;95%CI 1.53-2.43);200-299 mmHg亦相关(aOR 1.76;95%CI 1.37-2.25)。
  • 低氧血症<60 mmHg与死亡风险升高相关(aOR 1.45;95%CI 1.00-2.10)。

研究设计与关键结果

  • 回顾性分析,纳入3970例ECPR患者(中位年龄57岁;71%男性),中位ECMO持续时间4天(IQR 2-7天)。
  • SpO2-SaO2≥4%者634例(16%),<4%者3336例(84%);总体死亡率60%(2391例)。
  • SpO2-SaO2≥4%组死亡率67%(425例)vs. <4%组59%(1966例),p<0.001。
  • SpO2-SaO2≥4%组血清乳酸3.1 mmol/L vs. <4%组2.8 mmol/L,p=0.0017。
  • 多因素logistic回归校正预设协变量后,SpO2-SaO2≥4%与死亡风险升高相关(aOR 1.39;95%CI 1.13-1.71)。
  • 其他与死亡风险升高相关的因素:急性脑损伤(aOR 5.81;95%CI 4.70-7.20)、高氧血症≥300 mmHg(aOR 1.93;95%CI 1.53-2.43)、高氧血症200-299 mmHg(aOR 1.76;95%CI 1.37-2.25)、消化道出血(aOR 1.69;95%CI 1.42-2.00)、肾脏替代治疗(aOR 1.48;95%CI 1.03-2.11)、低氧血症<60 mmHg(aOR 1.45;95%CI 1.00-2.10)、年龄较大(aOR 1.19;95%CI 1.13-1.26)、乳酸较高(aOR 1.17;95%CI 1.13-1.20)。
  • 种族/民族与死亡率升高无关。

证据类型、等级与局限

  • 证据类型:回顾性分析,基于体外生命支持组织注册数据。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在ECPR患者中,ECMO支持24小时内SpO2-SaO2≥4%与院内死亡风险升高独立相关,作者认为可能源于未被识别的低氧血症,且与种族/民族无关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Previous studies have shown that inaccurate peripheral oxygen saturation (Sp o2 ) readings compared with arterial oxygen saturation (Sa o2 ) may occur in extracorporeal membrane oxygenation (ECMO) patients. We hypothesized that a greater Sp o2 -Sa o2 discrepancy in extracorporeal cardiopulmonary resuscitation (ECPR) patients is associated with higher mortality due to unrecognized hypoxemia.

DESIGN: Retrospective analysis.

SETTING: Data within the Extracorporeal Life Support Organization Registry from 496 ECMO centers (2018-2024).

PATIENTS: Patients 18 years old or older receiving ECPR (first-run only).

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Laboratory measurements including Sp o2 -Sa o2 were measured at 24 hours of ECMO support. Acute brain injury (ABI) included hypoxic-ischemic brain injury, ischemic stroke, intracranial hemorrhage, and seizures. Based on an inflection point in cubic spline analysis, a Sp o2 -Sa o2 threshold greater than or equal to 4% was used as a binary variable to assess its association with in-hospital mortality. Three thousand nine hundred seventy ECPR patients (median age, 57 yr; 71% male) were included. The median ECMO duration was 4 days (interquartile range, 2-7 d). There were 634 patients (16%) with Sp o2 -Sa o2 greater than or equal to 4% and 3336 (84%) with Sp o2 -Sa o2 less than 4%. Overall mortality was 60% ( n = 2391). Patients with Sp o2 -Sa o2 greater than or equal to 4% had higher mortality compared with patients with Sp o2 -Sa o2 less than 4% (67%, n = 425 vs. 59%, n = 1966; p < 0.001). Patients with Sp o2 -Sa o2 greater than or equal to 4% had higher serum lactate values than those with Sp o2 -Sa o2 less than 4% (3.1 vs. 2.8 mmol/L; p = 0.0017). In multivariable logistic regression adjusted for preselected covariates, Sp o2 -Sa o2 greater than or equal to 4% was associated with increased risk of mortality (adjusted odds ratio [aOR], 1.39; 95% CI, 1.13-1.71). Additional risk factors associated with higher mortality included ABI (aOR, 5.81; 95% CI, 4.70-7.20), hyperoxemia greater than or equal to 300 mm Hg (aOR, 1.93; 95% CI, 1.53-2.43), hyperoxemia 200-299 mm Hg (aOR, 1.76; 95% CI, 1.37-2.25), gastrointestinal hemorrhage (aOR, 1.69; 95% CI, 1.42-2.00), renal replacement therapy (aOR, 1.48; 95% CI, 1.03-2.11), hypoxemia less than 60 mm Hg (aOR, 1.45; 95% CI, 1.00-2.10), older age (aOR, 1.19; 95% CI, 1.13-1.26), and higher lactate (aOR, 1.17; 95% CI, 1.13-1.20). Race/ethnicity was not associated with higher mortality.

CONCLUSIONS: Sp o2 -Sa o2 greater than or equal to 4% in the first 24 hours after ECPR is associated with increased risk of mortality, potentially due to unrecognized hypoxemia, irrespective of race/ethnicity.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Kalra A, Wilcox C, Liu W, et al. Pulse Oximetry and Arterial Blood Gas Oxygen Saturation Discrepancies and Mortality in Extracorporeal Cardiopulmonary Resuscitation Patients: An Extracorporeal Life Support Organization Registry Analysis. Crit Care Med. 2025. PMID: 40521994. doi:10.1097/CCM.0000000000006736

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。